Form 4 for CNMD CONMED Corp
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-09 · accession 0001127602-23-018593 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-09 | CNMD | SHAGORY PETER K | EVP, STRAT, CORP DEVT | M - OptEx | $55.42 | +4,500 | 6,361 | +242% | +$249.4K |
| D | 2023-06-12 | 2023-06-09 | CNMD | SHAGORY PETER K | EVP, STRAT, CORP DEVT | F - Tax | $132.44 | -2,650 | 3,711 | -42% | -$351.0K |
| D | 2023-06-12 | 2023-06-09 | CNMD | SHAGORY PETER K | EVP, STRAT, CORP DEVT | M - OptEx | $0.00 | -4,500 | 4,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | M | A | 4,500 | $55.42 | 6,361 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-09 | F | D | 2,650 | $132.44 | 3,711 | D | — | — | |
| 3 | Derivative | Sars (Stock Appreciation Rights) | 2023-06-09 | M | D | 4,500 | $0.00 | 4,500 | D | $55.42 · — to 2025-05-11 | 4,500 Common Stock | (F1) The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |